Safety, bioavailability, and pharmacokinetics of VGX‐1027—A novel oral anti‐inflammatory drug in healthy human subjects

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 91-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of Deramciclane, a Novel Anxiolytic Agent, after Intravenous and Oral Administration

By Huupponen R.   Paija O.  

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 339-345

Adis International

Access to resources Recommend Favorite

Galectins: novel anti-inflammatory drug targets

By Liu Fu-Tong  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 4, 2002-08 ,pp. : 461-468

Informa Healthcare

Access to resources Recommend Favorite

Safety and Tolerability of Bismuthyl Ecabet Suspension, a Novel Anti-Ulcer Agent, following Single and Multiple Oral Dose Administration in Healthy Chinese Subjects

By Wang Yongqing  

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 247-252

Adis International

Access to resources Recommend Favorite

Mucoadhesive Buccal Systems as a Novel Strategy for Anti-Inflammatory Drugs Administration

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 10, Iss. 3, 2011-01 ,pp. : 190-202

Bentham Science Publishers

Access to resources Recommend Favorite